The union government is expected to come out with final regulations for the companies selling medicines online by the end of this month, Drugs Controller General of India Eswara Reddy said Friday.
The aim is to regulate online sale of medicines across the country and provide patients accessibility to genuine drugs from authentic portals only.
He said they already have examined the comments of stakeholders on draft regulations, which were released in September.
"The biggest hurdle for the growth of online pharmacy is that we do not have any regulations. By the end of this month, the government is going to finalise the regulations," he said here at the Global Venture Summit.
Currently, there are no regulations for such entities.
Regulations will help investors understand risk and benefits of investing in the sector, he added.
Currently, the market size of retail sale of medicines is about Rs 1.2 lakh crore. The market size of online sale of medicines is about Rs 3,500 crore, and is expected to increase to Rs 25,000 crore in the next 3-4 years, he said.
The habit-forming drugs (narcotic and psychotropic substances) would not be allowed to sale through this platform, he added.
In September, the Union health ministry came out with draft rules on sale of drugs by e-pharmacies.
According to the draft rules on 'sale of drugs by e-pharmacy', no person will be allowed to distribute or sell, stock, exhibit or offer for sale of drugs through e-pharmacy portal unless registered.
"Any person who intends to conduct business of e-pharmacy shall apply for the grant of registration to the Central Licensing Authority in Form 18AA through the online portal of the Central government," the draft notification had said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
